EMPLOYMENT AGREEMENTEmployment Agreement • March 15th, 2012 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”) is made and entered into as of this 16th day of March 2012, by and between Aegerion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Mark Andrew Rothera (the “Employee”).
November 28, 2011 Via Electronic Mail Delivery - Personal and Confidential Mr. John Cavan Allendale, NJ 07401-1107 Dear John:Aegerion Pharmaceuticals, Inc. • March 15th, 2012 • Pharmaceutical preparations • Massachusetts
As discussed, your employment with Aegerion Pharmaceuticals, Inc. (“Aegerion” or the “Company”) shall terminate effective February 29, 2012. This letter (the “Agreement”) summarizes the terms of your separation from employment and establishes an amicable arrangement under which you release the Company from any and all claims, and, in return, you receive severance pay and other benefits.
FIRST AMENDMENT TO LEASELease • March 15th, 2012 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS FIRST AMENDMENT TO LEASE, dated as of November 7, 2011 (this “Amendment”), between RREEF AMERICA REIT II CORP. PPP, a Maryland corporation (“Landlord”), and AEGERION PHARMACEUTICALS, INC. a Delaware corporation (“Tenant”), for certain premises located in the building in Riverfront Office Park at 101 Main Street, Cambridge, Massachusetts (“Building”).
